MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.27, no.3, pp.126-132, 2018 (ESCI)
Objective: The aim of this study is to investigate the clinical role of F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) in patients with carcinoma of unknown primary (CUP).